Oscar Health Inc. (OSCR)
Oscar Health Statistics
Share Statistics
Oscar Health has 215.05M shares outstanding. The number of shares has increased by 9.03% in one year.
Shares Outstanding | 215.05M |
Shares Change (YoY) | 9.03% |
Shares Change (QoQ) | 2.6% |
Owned by Institutions (%) | 81.03% |
Shares Floating | 175.86M |
Failed to Deliver (FTD) Shares | 985 |
FTD / Avg. Volume | 0.02% |
Short Selling Information
The latest short interest is 19.75M, so 9.33% of the outstanding shares have been sold short.
Short Interest | 19.75M |
Short % of Shares Out | 9.33% |
Short % of Float | 11.33% |
Short Ratio (days to cover) | 5.74 |
Valuation Ratios
The PE ratio is 127.04 and the forward PE ratio is 25.07. Oscar Health's PEG ratio is -1.17.
PE Ratio | 127.04 |
Forward PE | 25.07 |
PS Ratio | 0.35 |
Forward PS | 0.2 |
PB Ratio | 3.19 |
P/FCF Ratio | 3.4 |
PEG Ratio | -1.17 |
Enterprise Valuation
Oscar Health Inc. has an Enterprise Value (EV) of 456.61M.
EV / Earnings | 17.95 |
EV / Sales | 0.05 |
EV / EBITDA | 5.15 |
EV / EBIT | 7.97 |
EV / FCF | 0.48 |
Financial Position
The company has a current ratio of 0.82, with a Debt / Equity ratio of 0.3.
Current Ratio | 0.82 |
Quick Ratio | 0.82 |
Debt / Equity | 0.3 |
Total Debt / Capitalization | 22.81 |
Cash Flow / Debt | 3.27 |
Interest Coverage | 2.41 |
Financial Efficiency
Return on equity (ROE) is 0.03% and return on capital (ROIC) is 3.4%.
Return on Equity (ROE) | 0.03% |
Return on Assets (ROA) | 0.01% |
Return on Capital (ROIC) | 3.4% |
Revenue Per Employee | $3,823,985 |
Profits Per Employee | $10,596.67 |
Employee Count | 2,400 |
Asset Turnover | 1.9 |
Inventory Turnover | n/a |
Taxes
Income Tax | 7.3M |
Effective Tax Rate | 0.22 |
Stock Price Statistics
The stock price has increased by 1.29% in the last 52 weeks. The beta is 1.75, so Oscar Health's price volatility has been higher than the market average.
Beta | 1.75 |
52-Week Price Change | 1.29% |
50-Day Moving Average | 15.01 |
200-Day Moving Average | 16.59 |
Relative Strength Index (RSI) | 49.18 |
Average Volume (20 Days) | 4.61M |
Income Statement
In the last 12 months, Oscar Health had revenue of 9.18B and earned 25.43M in profits. Earnings per share was 0.11.
Revenue | 9.18B |
Gross Profit | 9.18B |
Operating Income | 57.27M |
Net Income | 25.43M |
EBITDA | 88.62M |
EBIT | 57.27M |
Earnings Per Share (EPS) | 0.11 |
Balance Sheet
The company has 1.53B in cash and 299.56M in debt, giving a net cash position of 1.23B.
Cash & Cash Equivalents | 1.53B |
Total Debt | 299.56M |
Net Cash | 1.23B |
Retained Earnings | -2.85B |
Total Assets | 4.84B |
Working Capital | -618.06M |
Cash Flow
In the last 12 months, operating cash flow was 978.19M and capital expenditures -27.9M, giving a free cash flow of 950.3M.
Operating Cash Flow | 978.19M |
Capital Expenditures | -27.9M |
Free Cash Flow | 950.3M |
FCF Per Share | 3.95 |
Margins
Gross margin is 100%, with operating and profit margins of 0.62% and 0.28%.
Gross Margin | 100% |
Operating Margin | 0.62% |
Pretax Margin | 0.36% |
Profit Margin | 0.28% |
EBITDA Margin | 0.97% |
EBIT Margin | 0.62% |
FCF Margin | 10.35% |
Dividends & Yields
OSCR does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Payout Ratio | n/a |
Earnings Yield | 0.78% |
FCF Yield | 31.25% |
Analyst Forecast
The average price target for OSCR is $21, which is 48.5% higher than the current price. The consensus rating is "Hold".
Price Target | $21 |
Price Target Difference | 48.5% |
Analyst Consensus | Hold |
Analyst Count | 7 |
Scores
Altman Z-Score | 1.4 |
Piotroski F-Score | 6 |